Writing the summary…
CNBC Daily Open: May the 'AI Force' be with you
Original reporting
CNBC: read the full reportRelated stories

Nvidia boss rejects AI extinction fears as 'doomsday narratives'
Jensen Huang's comments come after warnings from AI researchers that the technology could lead to human extinction.

‘RAMageddon’: tech crunch hikes the price of your next iPhone by £100
Shortage of memory chips and other critical components reverses trend of electronics becoming cheaper Apple’s recent product launch caused headlines around the world as it unveiled its first folding phone. But hidden in the slick technology showcase was a nasty surprise: a £100 increase in the price of all iPhones, including older models. It is blamed on “RAMageddon”, which has reversed a decades-long trend of electronics becoming cheaper. It is the fallout from the AI gold rush hoovering up every memory chip available for vast datacentres. This has led to a severe shortage of the chips, and other critical components, for electronics, including phones. Continue reading...
Oil falls as crude flows remain 'surprisingly strong'
Oil fell Monday, as traders keep watch for a recovery in shipments from Saudi Arabia, even as Mideast tensions continue to escalate.

US and China discuss AI safety plan ahead of Trump-Xi summit
Top US and Chinese officials held talks in New York on Sunday ahead of a Trump-Xi summit this week.

How Saudi oil scientists ended up working on the world’s most important climate reports
Guardian investigation reveals fossil fuel links of IPCC authors, with experts declaring the body’s conflict of interest policy ‘not fit for purpose’ On her first day as an expert author on the world’s most important climate reports, Prof Julia Steinberger knew nobody else, so she sat down at a stranger’s table for breakfast. “Hi, I’m Julia. I’m from the University of Lausanne,” she said. The man across the table replied: “I’m Mustafa Babiker. I work with Saudi Aramco.” Continue reading...
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.